Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016

Case reports have identified invasive fungal diseases in persons who use cannabis, and fungal contamination of cannabis has been described. In a large health insurance claims database, persons who used cannabis were 3.5 (95% CI 2.6–4.8) times more likely than persons who did not use cannabis to have...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedict, Kaitlin, Thompson, George R., Jackson, Brendan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258471/
https://www.ncbi.nlm.nih.gov/pubmed/32441624
http://dx.doi.org/10.3201/eid2606.191570
_version_ 1783540088764891136
author Benedict, Kaitlin
Thompson, George R.
Jackson, Brendan R.
author_facet Benedict, Kaitlin
Thompson, George R.
Jackson, Brendan R.
author_sort Benedict, Kaitlin
collection PubMed
description Case reports have identified invasive fungal diseases in persons who use cannabis, and fungal contamination of cannabis has been described. In a large health insurance claims database, persons who used cannabis were 3.5 (95% CI 2.6–4.8) times more likely than persons who did not use cannabis to have a fungal infection in 2016.
format Online
Article
Text
id pubmed-7258471
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-72584712020-06-09 Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016 Benedict, Kaitlin Thompson, George R. Jackson, Brendan R. Emerg Infect Dis Dispatch Case reports have identified invasive fungal diseases in persons who use cannabis, and fungal contamination of cannabis has been described. In a large health insurance claims database, persons who used cannabis were 3.5 (95% CI 2.6–4.8) times more likely than persons who did not use cannabis to have a fungal infection in 2016. Centers for Disease Control and Prevention 2020-06 /pmc/articles/PMC7258471/ /pubmed/32441624 http://dx.doi.org/10.3201/eid2606.191570 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Benedict, Kaitlin
Thompson, George R.
Jackson, Brendan R.
Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
title Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
title_full Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
title_fullStr Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
title_full_unstemmed Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
title_short Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
title_sort cannabis use and fungal infections in a commercially insured population, united states, 2016
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258471/
https://www.ncbi.nlm.nih.gov/pubmed/32441624
http://dx.doi.org/10.3201/eid2606.191570
work_keys_str_mv AT benedictkaitlin cannabisuseandfungalinfectionsinacommerciallyinsuredpopulationunitedstates2016
AT thompsongeorger cannabisuseandfungalinfectionsinacommerciallyinsuredpopulationunitedstates2016
AT jacksonbrendanr cannabisuseandfungalinfectionsinacommerciallyinsuredpopulationunitedstates2016

Ejemplares similares